SUN Pharmaceutical Industries Limited Mesalamine Export Data — India (DGFT 2022–2026)

Name: SUN Pharmaceutical Industries Limited Mesalamine Export Records India — #2 Exporter, 207 Shipments, $10.3M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Mesalamine

India Pharmaceutical Trade Intelligence

$1.3B103 Suppliers51 CountriesHS 30049099

ExportsIndia → UNITED STATES98.6%India → RUSSIA0.4%

ImportsUNITED STATES → India$1.0M ISRAEL → India$27.3K

#1 Supplier: ZYDUS LIFESCIENCES #1 Buyer: EVERSANA LIFE

SUN Pharmaceutical Industries Limited — Mesalamine Exporter #2 | $11.1M Trade Value | TransData Nexus | TransData Nexus

SUN Pharmaceutical Industries Limited — Mesalamine Exporter Profile

Indian Pharmaceutical Exporter · #2 for Mesalamine · $11.1M export value · DGFT Verified

SUN Pharmaceutical Industries Limited is the #2 Indian exporter of Mesalamine with $11.1M in export value and 207 verified shipments. SUN Pharmaceutical Industries Limited holds a 0.8% market share in Mesalamine exports across 11 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.

SUN Pharmaceutical Industries Limited — Mesalamine Export Profile: Buyers & Destinations

SUN Pharmaceutical Industries Limited Mesalamine export treemap — buyers and destination countries | TransData Nexus

Where Does SUN Pharmaceutical Industries Limited Export Mesalamine?

Country	Value	Shipments	Share
UNITED STATES	$5.8M	135	60.5%
RUSSIA	$1.9M	38	19.2%
LITHUANIA	$584.1K	12	6.1%
AUSTRALIA	$550.0K	11

Who Are the Top Buyers of Mesalamine from SUN Pharmaceutical Industries Limited?

Buyer	Country	Value	Orders
SUN PHARMACEUTICAL INDUSTRIES,INC.	UNITED STATES	$1.9M	42
SUN PHARMACEUTICAL INDUSTRIES INC	UNITED STATES	$1.7M	37
AO RANBAXY	RUSSIA	$1.2M	24
SUN PHARMACEUTICAL INDUSTRIES,INC	UNITED STATES	$985.3K	23
AO "RANBAXY"	RUSSIA	$600.0K	12
SUN PHARMACEUTICAL INDUSTRIES, INC.	UNITED STATES	$522.3K	15
SUN PHARMA ANZ PTY LTD	AUSTRALIA	$300.0K	6
SUN PHARMACEUTICAL INDUSTRIES INC.	UNITED STATES	$300.0K	6
UAB VILNIAUS TRANZITAS	LITHUANIA	$250.0K	5
SUN PHARMA ANZ PTY LIMITED	AUSTRALIA	$250.0K	5

SUN Pharmaceutical Industries Limited supplies Mesalamine to 31 buyers globally. The largest buyer is SUN PHARMACEUTICAL INDUSTRIES,INC. (UNITED STATES), followed by SUN PHARMACEUTICAL INDUSTRIES INC (UNITED STATES) and AO RANBAXY (RUSSIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Mesalamine Formulations Does SUN Pharmaceutical Industries Limited Export?

Product Description / Formulation	Value	Shipments
MESALAMINE DELAYED RELEASE TABLET 1.2GM	$1.5M	32
MESALAMINE DELAYED RELEASE TABLET 1.2GM(PACK : 01*120)	$514.7K	16
MESALAMINE DELAYED RELEASE TABLET 1.2GMPACK : 01*120 (BATCH NO AS PER INVOICE)	$450.0K	9
MESALAMINE DELAYED RELEASE TABLET 1.2GMPACK : 01*120 Batch No. As Per DOCUMENT	$350.0K	7
MESALAMINE ER CAPS USP 500MG120'SUSA-C	$300.0K	6
MESACOL 400MG TABLETS CONTAINS MESALAMINE PACK : BOX5X10SNOS	$300.0K	6
MESALAMINE DELAYED RELEASE TABLET 1.2GM,	$250.0K	5
MESALAMINE DELAYED RELEASE TABLET 1.2GMPACK : 01*120 Bottle Batch No. As Per DOCUMENT	$165.8K	4
MESALAMINE DELAYED RELEASE TABLETS USP 1	$150.0K	3
MESALAMINE DELAYED RELEASE TABLETS 1.2GM[9360 PACKS X 1X120'S]NOS	$150.0K	3

SUN Pharmaceutical Industries Limited exports 105 distinct Mesalamine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is MESALAMINE DELAYED RELEASE TABLET 1.2GM with 32 shipments worth $1.5M.

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Mesalamine Exporters?

Exporters ranked immediately above and below #2 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	ZYDUS LIFESCIENCES LIMITED	$19.3M	386	6	$50.0K
2	SUN PHARMACEUTICAL INDUSTRIES LIMITED ★	$10.3M	207	11	$50.0K
4	ANNORA PHARMA PRIVATE LIMITED	$7.8M	157	1	$50.0K
8	ALKEM LABORATORIES LIMITED	$2.6M	52	1	$50.0K

SUN Pharmaceutical Industries Limited ranks #2 among 103 Indian Mesalamine exporters. Average shipment value of $50.0K compared to the market average of $469.7K. The closest competitors by value are ZYDUS LIFESCIENCES LIMITED and ANNORA PHARMA PRIVATE LIMITED.

Which Indian Ports Ship Mesalamine Exports?

Port	Shipments	% Share
DELHI AIR CARGO ACC (INDEL4)	801	21.2%
SAHAR AIR	789	20.9%
DELHI AIR	494	13.1%
SAHAR AIR CARGO ACC (INBOM4)	415	11.0%
MUNDRA SEA	134	3.5%
Delhi Air	131	3.5%
Bombay Air	120	3.2%
NHAVA SHEVA SEA (INNSA1)	70	1.9%

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Mesalamine Exports

Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)

In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)

The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)

Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Mesalamine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 222 individual customs records matching SUN Pharmaceutical Industries Limited exporting Mesalamine, covering 105 formulations to 12 countries via 31 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 51+ countries, 214+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Mesalamine

Mesalamine

SUN Pharmaceutical Industries Limited — Mesalamine Exporter Profile

SUN Pharmaceutical Industries Limited — Mesalamine Export Profile: Buyers & Destinations

Where Does SUN Pharmaceutical Industries Limited Export Mesalamine?

Who Are the Top Buyers of Mesalamine from SUN Pharmaceutical Industries Limited?

What Is India's Total Mesalamine Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?

What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Mesalamine Exports?

How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Mesalamine Exporters?

What Mesalamine Formulations Does SUN Pharmaceutical Industries Limited Export?

Regulatory Requirements: Exporting Mesalamine to Key Markets

United States — FDA

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Mesalamine Exporters?

Which Indian Ports Ship Mesalamine Exports?

What Other Gastrointestinal Products Does SUN Pharmaceutical Industries Limited Export?

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Mesalamine Exports

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

About SUN Pharmaceutical Industries Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Mesalamine Export Data from SUN Pharmaceutical Industries Limited

Mesalamine Stats

Company Overview

Top Products by SUN Pharmaceutical Industries Limited

Related Analysis

Need Detailed Export Data?

Data Source